U.S. Wealth Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.56M Sell
17,209
-50
-0.3% -$13.2K 2.59% 12
2026
Q2
$1.38M Buy
17,259
+2,266
+15% +$528K 0.83% 33
2026
Q1
$3.66M Sell
14,993
-56
-0.4% -$13K 2.48% 15
2025
Q4
$3.11M Sell
15,049
-116
-0.8% -$22.9K 2.05% 18
2025
Q3
$2.81M Buy
15,165
+650
+4% +$111K 1.84% 21
2025
Q2
$2.22M Buy
14,515
+833
+6% +$128K 1.73% 29
2025
Q1
$2.32M Sell
13,682
-624
-4% -$97.6K 1.84% 24
2024
Q4
$2.07M Buy
+14,306
New +$2.22M 1.56% 30

Other funds holding JNJ

U.S. Wealth Group's JNJ Position: Q3 2026 in Review

U.S. Wealth Group reduced its Johnson & Johnson (JNJ) stake by 0.29% in Q3 2026, selling an estimated $13.2K and leaving 17,209 shares worth $4.56M. The position accounts for 2.59% of the portfolio, ranked #12.

U.S. Wealth Group first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • U.S. Wealth Group held 17,209 shares of Johnson & Johnson worth $4.56M as of Q3 2026.
  • U.S. Wealth Group sold 50 Johnson & Johnson shares in Q3 2026, an estimated $13.2K.
  • Johnson & Johnson made up 2.59% of U.S. Wealth Group's portfolio in Q3 2026, its #12 holding.
  • U.S. Wealth Group first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on U.S. Wealth Group's 13F filing for Q3 2026, filed 9 Nov 2026.